Loading clinical trials...

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass | Clinical Trials | Clareo Health

Active Not RecruitingNCT07132788

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

Patients with pulmonary arterial hypertension (PAH) are at increased risk of muscle loss and decreased physical activity. This study will aim to (1) understand the way in which muscle loss occurs in P...

Lead sponsor: University of Pennsylvania•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

RECRUITINGPhase 2

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820 · Pulmonary Hypertension

RECRUITINGNA

Development of Novel Physiological CMR Methods in Health and Disease

NCT03854071 · Heart Failure, Pulmonary Hypertension, and more

RECRUITING

Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders

NCT07477197 · Adult Congenital Heart Disease, Pulmonary Hypertension, and more

RECRUITINGPhase 1

Preliminary Human Trials of F230 Tablets

NCT06899815 · Pulmonary Hypertension

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 20, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment150

Start dateMay 2025

Last updatedAug 20, 2025

Condition

Pulmonary Hypertension

Locations shown

University of Pennsylvania Hospital

Philadelphia, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 20, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions